日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-world treatment patterns of Bruton tyrosine kinase inhibitors in mantle cell lymphoma in a community oncology setting

在社区肿瘤科环境中，布鲁顿酪氨酸激酶抑制剂治疗套细胞淋巴瘤的真实世界治疗模式

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2554354
Shah, Bijal D; Xue, Mei; Furnback, Wesley; Yang, Keri
肿瘤
肿瘤免疫
信号转导
淋巴瘤
细胞生物学
发表日期：2025
文献求助 收藏

A Systematic Literature Review of the Economic and Healthcare Resource Utilization Burden of Relapsed/Refractory Follicular Lymphoma

复发/难治性滤泡性淋巴瘤的经济和医疗资源利用负担的系统性文献综述

期刊:Pharmacoeconomics-Open
影响因子:2.1
doi:10.1007/s41669-025-00577-z
Shah, Bijal; Xue, Mei; Furnback, Wesley; Seymour, Erlene K; Kim, Jin; Chuang, Po-Ya; Dec, Madeline; Yang, Keri
淋巴瘤
发表日期：2025
文献求助 收藏

Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer

评估肿瘤电场治疗（TTFields）联合免疫检查点抑制剂或多西他赛治疗转移性非小细胞肺癌的成本效益

期刊:
影响因子:
doi:10.2147/CEOR.S501532
Furnback, Wesley; Wu, Elizabeth; Koh, Cloe Ying Chee; Nino de Rivera Guzman, Jorge Fernando; Kruhl, Christian; Kotecha, Rupesh; Wang, Bruce C M
Checkpoint
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

The financial value of improving patient access to COVID-19 antiviral therapy in Medicare Part D: A simulation study

改善患者在联邦医疗保险D部分获得COVID-19抗病毒治疗的经济价值：一项模拟研究

期刊:
影响因子:
doi:10.18553/jmcp.2025.24348
Aguilar, Andrew S; Engel, Tyler; Furnback, Wesley; Dieguez, Gabriela; Campbell, David J; Diner, Benjamin; Sullivan, Sean D; Dorling, William
微生物学
发表日期：2025
文献求助 收藏

Clinical Trial and Real-World Outcomes of Patients With Metastatic NSCLC in the Post-Platinum-Based Chemotherapy Failure Setting

铂类化疗失败后转移性非小细胞肺癌患者的临床试验和真实世界结局

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2023.100579
Soon, Yu Yang; Furnback, Wesley; Kim, Jin; Chuang, Po-Ya; Chavez, Gordon; Proescholdt, Christina; Chee Koh, Cloe Ying
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database (NHIRD)

利用台湾全民健康保险研究数据库（NHIRD）评估接受生物制剂类风湿关节炎治疗患者的疗效和经济负担

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0193489
Shi, Qiang; Li, Ko-Jen; Treuer, Tamas; Wang, Bruce C M; Gaich, Carol L; Lee, Chien-Hsun; Wu, Wen-Shuo; Furnback, Wesley; Tang, Chao-Hsiun
关节炎
发表日期：2018
文献求助 收藏

The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China

在中国，普瑞巴林与加巴喷丁治疗周围神经性疼痛（pNeP）和带状疱疹后神经痛（PHN）的成本效益分析

期刊:Pain and Therapy
影响因子:3.3
doi:10.1007/s40122-016-0048-z
Wang, Bruce C M; Liu, Dongdong; Furnback, Wesley E; Bifa, Fan; Dong, Peng; Xie, Li; Guzauskas, Gregory F; Zhang, Sali
微生物学
疱疹
发表日期：2016
文献求助 收藏

Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value

精准健康经济学和结果研究助力精准医疗：大数据与患者异质性携手迈向价值之路

期刊:Journal of Personalized Medicine
影响因子:3
doi:10.3390/jpm6040020
Chen, Yixi; Guzauskas, Gregory F; Gu, Chengming; Wang, Bruce C M; Furnback, Wesley E; Xie, Guotong; Dong, Peng; Garrison, Louis P
发表日期：2016
文献求助 收藏

The cost reduction in hospitalization associated with paliperidone palmitate in the People's Republic of China, Korea, and Malaysia

在中国、韩国和马来西亚，帕利哌酮棕榈酸酯可降低住院费用

期刊:
影响因子:
doi:10.2147/NDT.S86722
Chiou, Chiun-Fang; Wang, Bruce Cm; Caldwell, Ronald; Furnback, Wesley; Lee, Jung-Sun; Kothandaraman, Nathan; Lee, SunKyoung; Wang, Jin; Zhang, Fan
发表日期：2015
文献求助 收藏